EG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Everest Group Ltd is a reasonable buy right now for a beginner-focused, long-term investor with $50,000-$100,000 available. The stock is not showing a strong momentum breakout, but the fundamentals and earnings power are improving, insider buying is strong, analyst targets are generally supportive, and the current price remains below several recent price targets. Given the investor is impatient and does not want to wait for a perfect entry, this is a solid buy now rather than a stock to keep waiting on.
The price is essentially flat on the day at 351.71, with the stock trading just below the pivot level of 348.01 and under resistance at 358.17. The moving averages are constructive with SMA_5 > SMA_20 > SMA_200, which supports the broader uptrend. However, MACD histogram is slightly negative and expanding, showing near-term momentum has weakened. RSI at 57.63 is neutral to mildly bullish, so the stock is not overbought. Overall, the chart is still bullish on a medium-term basis, but near-term upside is not explosive.
["Q1 2026 EPS beat expectations materially at $16.08 versus $13.98 expected.", "Net income and EPS grew sharply year over year, showing strong earnings momentum.", "The company raised its quarterly minimum share buyback to $300 million, a shareholder-friendly catalyst.", "Shift toward higher-margin specialty insurance products can support future profitability.", "Insiders are buying, with buying amount up 1216.20% over the last month.", "Several analysts lifted price targets, and some maintain Buy/Overweight ratings.", "The stock is below some of the higher analyst price targets, leaving upside room."]
["Q1 2026 revenue fell 4.6% year over year and missed expectations.", "Gross written premiums declined 18%, indicating softer top-line growth.", "MACD is negative and weakening, suggesting near-term momentum is not strong.", "Congress trading data shows 1 sale and 0 purchases, indicating cautious political sentiment.", "Hedge funds are neutral with no significant trading trends over the last quarter."]
In Q1 2026, Everest Group showed mixed but improving financial quality. Revenue declined 4.62% year over year to $4.068 billion, which is the main weak point. However, profitability improved sharply: net income rose 213.94% year over year to $653 million and EPS increased 229.47% to $16.21. This indicates the latest quarter season was strong on earnings and margin quality despite weaker top-line growth.
Analyst sentiment is mixed but generally constructive. Recent target moves include several raises from Morgan Stanley, Mizuho, UBS, Wells Fargo, BofA, Barclays, and Keefe Bruyette. Ratings are split between Neutral/Equal Weight and Buy/Overweight, with price targets ranging roughly from $332 to $454. The Wall Street pros view is that Everest has solid capital deployment, margins, and book value growth potential, while the cons are sluggish premium growth, revenue pressure, and a challenging setup for top-line acceleration. Overall, analysts are cautious-to-positive rather than aggressively bullish.
